Impact Genome Project

The Impact Genome Project is a social impact data and analytics platform that standardizes the measurement of social outcomes, including public health and social determinants of health. By utilizing a proprietary taxonomy to code social programs, the project enables organizations to benchmark efficacy, calculate cost-per-outcome, and verify social results with scientific rigor. The platform serves as a centralized registry for evidence-based interventions, helping funders, corporations, and policymakers allocate resources to the most effective health and social initiatives. It features a specific Health Genome component that maps outcomes related to disease prevention, access to care, and health equity. In 2022, the project was acquired by APCO Worldwide to integrate its data-driven insights into global ESG and social impact advisory services.